Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice
SARS-CoV-2 is a newly emerged coronavirus, causing the global pandemic of respiratory coronavirus disease (COVID-19). The type I interferon (IFN) pathway is of particular importance for anti-viral defense and recent studies identified that type I IFNs drive early inflammatory responses to SARS-CoV-2...
Main Authors: | Ogger, PP, Garcia Martín, M, Michalaki, C, Zhou, J, Brown, JC, Du, Y, Miah, KM, Habib, O, Hyde, SC, Gill, DR, Barclay, WS, Johansson, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2022
|
Similar Items
-
Dysregulated Interferon Response Underlying Severe COVID-19
by: LeAnn Lopez, et al.
Published: (2020-12-01) -
Interferon-Independent Innate Responses to Cytomegalovirus
by: Caroline L. Ashley, et al.
Published: (2019-12-01) -
Interferon β, an enhancer of the innate immune response against SARS-CoV-2 infection
by: Kali, Suresh Kumar, et al.
Published: (2022) -
Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses
by: Xiaoming Sun, et al.
Published: (2022-11-01) -
Transcriptome profiling of monocytes from XLA patients revealed the innate immune function dysregulation due to the BTK gene expression deficiency
by: Mirsafian, H., et al.
Published: (2017)